Addition Of Atrial Natriuretic Peptide Research Articles

Effects of atrial natriuretic peptide on isolated bovine mesenteric lymph vessels

The mode of action of atrial natriuretic peptide (ANP) on bovine mesenteric lymphatics was investigated by recording isometric tensions in isolated cylindrical segments. ANP in concentrations from 5 to 30 ng/ml caused dose-related decreases in the rhythm and amplitude of spontaneous contractions. No tachyphylaxis was observed in the ANP-induced responses in lymph vessels. Addition of ANP in a low concentration ranging from 3 to 100 ng/ml produced a dose-dependent relaxation in the lymphatic preparations precontracted by 10(-7) M bradykinin. The ANP-induced relaxation was not modified by pretreatment with 5 x 10(-7) M propranolol, 5 x 10(-7) M atropine, 10(-6) M cimetidine, 5 x 10(-5) M aspirin, or 10(-5) M ouabain. The mechanical rubbing of endothelial cells in the lymph vessels caused no significant effect on the ANP-induced relaxation. The relaxation, however, was significantly reduced by pretreatment with 10(-5) M methylene blue. These results suggest that ANP in a low concentration seems to inhibit lymph transport through a reduction of spontaneous contractions and a marked relaxation of lymphatic smooth muscles in bovine mesenteric lymphatics and that ANP may produce the relaxation through synthesis of guanosine 3',5' cyclic monophosphate, independent of the lymphatic endothelium.

ANP INDUCES WATER AND ELECTROLYTE SECRETION IN THE IN VIVO RAT PERFUSED JEJUNUM

Atrial natriuretic peptide (ANP) is involved in the renal regulation of water and electrolyte homeostasis. ANP exerts its effects through the stimulation of the guanylate cyclase (GC)-cGMP system. Conflicting data have been reported concerning the effects and the mechanism of action of ANP in the intestine. Aims of the work were: 1) to see whether ANP affects the intestinal water and electrolyte transport and 2) to investigate its mechanism of action and namely the binding of ANP to intestinal cells or membranes and its effects on the GC-cGMP system. Intravenous administration of ANP (0.3ug/Kg/30min) resulted in a significant shift of water, sodium and chloride absorption toward secretion in the vivo perfused rat jejunum. Such effect was prompt, but of short duration (less than 10 minutes on a continued ANP infusion). No effect was observed on potassium transport. The effects of the addition of 3-28 rat ANP in a concentration range of 10−8 to 10−SM on GC and on cGMP were studied using rat jejunal homogenates and rat jejunal cells. GC and cGMP were measured at various times after the addition of ANP. 2 minutes after the addition on ANP, a modest (1.5 times) increase of both GC and cGMP was observed which rapidly returned to basal levels. No specific binding was obtained by incubating 125I-ANP with basolateral membranes, cells or homogenates prepared from rat jejunum. We conclude that ANP may play a role as a short-lived modulator in the intestinal regulation of water and electrolyte homeostasis. The mechanism of such interaction appears to be indirect, since it does not involve the GC-cGMP system nor is mediated by specific binding sites on the enterocyte.

Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide

Regional differences in responses of isolated monkey arteries and veins to atrial natriuretic peptide were investigated by recording isometric tension. Addition of atrial natriuretic peptide (4 X 10(-12) to 4 X 10(-8) M) produced a concentration-dependent relaxation in isolated monkey arteries and veins. No significant difference was observed between the responses to rat and human atrial natriuretic peptides. A marked heterogeneity in responses to rat atrial natriuretic peptide, however, was observed in arterial preparations. The decreasing order of the response was as follows: renal greater than pulmonary greater than femoral = mesenteric greater than coronary greater than middle cerebral greater than basilar arteries. A heterogeneity in the relaxation produced by atrial natriuretic peptide was also observed in monkey veins. The decreasing order of the response was as follows: pulmonary greater than mesenteric = portal greater than femoral greater than renal = inferior caval veins. On the other hand, 10(-5) M sodium nitroprusside caused a maximal relaxation in all monkey arteries and veins used. In the middle cerebral, basilar, and coronary arteries, the relaxant effects of rat atrial natriuretic peptide on KCl-induced contraction were significantly smaller than those on the preparations contracted by an agonist such as prostaglandin F2 alpha. These results suggest that there exist profound regional vasorelaxant selectivities of atrial natriuretic peptide in isolated monkey arteries and veins.

Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.

The effect of atrial natriuretic peptide (ANP), arginine vasopressin (AVP), and oxytocin (OT) on cAMP and cGMP accumulation was investigated in LLC-PK1 kidney epithelial cells. The addition of ANP, AVP, and OT to intact cells produced a time- and concentration-dependent increase in cGMP accumulation. ANP produced a 1.7-fold increase in cGMP at 10 pM and a maximal 28-fold increase in cGMP at 1 microM. ANP had no effect on basal or AVP-induced stimulation of cAMP accumulation. OT was 10-fold more potent than AVP at increasing cGMP levels, producing a 2.1-fold increase in cGMP at 0.1 nM, whereas AVP was 100-fold more potent at increasing cAMP levels. At a concentration of 1 microM, AVP and OT produced a maximal 12 to 14-fold increase in cGMP, while OT and AVP produced 50- and 90-fold increase in cAMP, respectively. The selective OT agonist [Thr4, Gly7]oxytocin was very effective at increasing cGMP, but not at increasing cAMP levels. The V2-vasopressin agonist [deamino-Pen1,Val4, D-Arg8]vasopressin did not increase cGMP levels, but produced a 20-fold increase in cAMP levels. The addition of ANP together with either AVP or OT produced an additive increase in cGMP content. Simultaneous addition of AVP and OT did not lead to a greater increase in cAMP or cGMP levels. These results suggest that the AVP- and OT-induced increase in cGMP is mediated by OT receptors, whereas the increase in cAMP is probably mediated by vasopressin receptors. ANP increased the activity of particulate guanylate cyclase by 6-fold, while AVP and OT has no effect on particulate guanylate cyclase activity. The relatively selective inhibitor of soluble guanylate cyclase, methylene blue, had no effect on the ANP-induced increase in cGMP content in intact cells, but produced a 50% inhibition of the increase in cGMP by AVP and OT. Methylene blue did not alter the stimulation of cAMP by AVP or OT. These results demonstrate that ANP, AVP, and OT increase cGMP in LLC-PK1 kidney epithelial cells. The increase in cGMP by ANP is mediated by particulate guanylate cyclase, whereas AVP and OT probably increase cGMP by interacting with OT receptors coupled to soluble guanylate cyclase.